IHS Chemical Week

World News and Views :: Projects

DSM Divests Biologics Plant; Focuses on Cell Technology

1:20 PM MDT | June 13, 2007 | Alex Scott

DSM says it has sold its biologic drugs plant at Montreal to AstraZeneca for an undisclosed sum. The Montreal facility was DSM’s only commercial manufacturing plant for biologic drugs. The company says it plans to focus its biologics activities on developing manufacturing technologies and services. Staal: Change of strategy for biologics. DSM says it mothballed the Montreal plant in December 2005 due to a lack of orders for products from the facility. DSM says it will book a “small profit” from the divestment but it declined to provide...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa